Loading the section
Company reports as filed with the U.S. Securities and Exchange Commission.
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Revenue | 2.19B | 1.67B |
| Cost of revenue | 263M | 208M |
| Gross profit | 1.92B | 1.47B |
| Research and development | 935M | 310M |
| Selling, general and administrative | 512M | 177M |
| Operating expenses | 2.96B | 1.53B |
| Operating income | −1.04B | −62M |
| Pre-tax income | −1.01B | −23M |
| Income tax | 831,000 | 3M |
| Net income | −1.01B | −25M |
| Earnings per share | −4.27 | −0.39 |
| Earnings per share, diluted | −4.27 | −0.39 |
| Weighted average shares | 236M | 65M |
| Weighted average shares, diluted | 236M | 65M |
| Metric | 31 Mar 2026 | 31 Dec 2025 | 30 Sept 2025 | 30 Jun 2025 | 31 Mar 2025 | 31 Dec 2024 | 30 Sept 2024 | 30 Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 608M | 466M | 445M | 868M | 318M | 338M | 271M | 295M |
| Receivables | 294M | 258M | 238M |
| Metric | 31 Dec 2025 | 31 Dec 2024 |
|---|---|---|
| Operating cash flow | 53M | 64M |
| Depreciation and amortisation | 30M | 25M |
| Share-based compensation | 1.07B | 30M |
| Capital expenditure | 20M | 5M |
| Investing cash flow | −290M | 46M |
| Share buybacks | 78M | 950,000 |
Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator
| 230M |
| — |
| 216M |
| — |
| — |
| Current assets | 1.74B | 1.76B | 1.76B | 1.74B | — | 1.29B | — | — |
| Property, plant and equipment | — | — | 86M | 89M | — | 93M | — | — |
| Total assets | 1.95B | 1.96B | 1.96B | 1.90B | — | 1.46B | — | — |
| Current liabilities | 344M | 388M | 356M | 360M | — | 375M | — | — |
| Total liabilities | 509M | 563M | 519M | 474M | — | 502M | — | — |
| Equity | 1.44B | 1.40B | 1.44B | 1.43B | −1.91B | −1.93B | −1.92B | −1.91B |
| Shares outstanding | — | 0 | 0 | 0 | — | 67M | — | — |
| Shares issued | — | 0 | 0 | 0 | — | 67M | — | — |
| Financing cash flow | 368M | 456,000 |